• Home
  • Clinical
    • Clinical Studies/Trials
    • Congresses and Meetings
    • More…
  • Companies
    • Mergers and Acquisitions
    • Company News
    • Financial
    • More…
  • Specialty
    • Cardio
    • Vascular
    • Orthopaedics
    • Neuro
    • Spine
    • More…
  • News
    • Editorial
    • USA
  • Publish
    • Advertising
    • Contact
  • Home
  • Clinical
    • Clinical Studies/Trials
    • Congresses and Meetings
    • More…
  • Companies
    • Mergers and Acquisitions
    • Company News
    • Financial
    • More…
  • Specialty
    • Cardio
    • Vascular
    • Orthopaedics
    • Neuro
    • Spine
    • More…
  • News
    • Editorial
    • USA
  • Publish
    • Advertising
    • Contact
Medlatest – Medical Device News
medical
device
news

Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo

Alere receives FDA Approval for Alere Determine™ HIV-1/2 Ag/Ab Combo (via PR Newswire)

WALTHAM, Mass., Aug. 9, 2013 /PRNewswire/ — Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information, announced today that it has received…



 
August 12, 2013 - in: Categories Approval/Clearance
linkedin iconLinkedIn
twitter iconTweet
facebook iconShare
whatsapp icon
email iconE-mail

Post navigation

Previous Previous post: FDA Approves LDR’s Mobi-C Cervical Disc for One-Level Use
Next Next post: Medtronic Buys Cardiocom in Broader “Healthcare” Initiative
Follow on Twitter Follow @medlatest

Sign up for our Daily Digest email:

* indicates required

Hill Woods Medical Media Logo

Medtech Communications

Medical Device and Lifescience Recruitment
We support the BMA's Medical Fair and Ethical Trade Group's aims
Tweets by medlatest
  • Home
  • Contact
  • About
  • Site Map
  • Privacy
  • Cookies
  • Ts&Cs
  • Copyright
  • Disclaimer
  • Linking
© Medlatest – Medical Device News 2021
∧